Desirudin: a review of the pharmacology and clinical application for the prevention of deep vein thrombosis. (Q37935774)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21932952%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

review article

1 reference

title

Desirudin: a review of the pharmacology and clinical application for the prevention of deep vein thrombosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21932952%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

0 references

1 reference

ChEBI release 2020-05-28

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21932952%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

author name string

Thomas J Graetz

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21932952%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Bethany R Tellor

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21932952%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Jennifer R Smith

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21932952%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

publication date

1 September 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21932952%20AND%20SRC:MED&resulttype=core&format=json

Expert Review of Cardiovascular Therapy

13 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21932952%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21932952%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21932952%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

page(s)

1101-1109

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21932952%20AND%20SRC:MED&resulttype=core&format=json

New therapeutic options in deep vein thrombosis prophylaxis.

13 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.131

Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.131

Frequency of deep venous thrombosis in asymptomatic patients with coronary artery bypass grafts

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.131

Heparin-induced thrombocytopenia: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.131

Treatment and prevention of heparin-induced thrombocytopenia: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.131

Prevalence of heparin-associated antibodies without thrombosis in patients undergoing cardiopulmonary bypass surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.131

Antibodies to platelet factor 4-heparin after cardiopulmonary bypass in patients anticoagulated with unfractionated heparin or a low-molecular-weight heparin : clinical implications for heparin-induced thrombocytopenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.131

Incidence and clinical relevance of anti-platelet factor 4/heparin antibodies before cardiac surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.131

Complications from heparin-induced thrombocytopenia in patients undergoing cardiopulmonary bypass

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.131

Heparin-induced thrombocytopenia: temporal pattern of thrombocytopenia in relation to initial use or reexposure to heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.131

Temporal aspects of heparin-induced thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.131

What is the potential for overdiagnosis of heparin-induced thrombocytopenia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.131

The 4Ts scoring system for heparin-induced thrombocytopenia in medical-surgical intensive care unit patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.131

The laboratory diagnosis and clinical management of patients with heparin-induced thrombocytopenia: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.131

Early-onset and persisting thrombocytopenia in post-cardiac surgery patients is rarely due to heparin-induced thrombocytopenia, even when antibody tests are positive

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.131

A clinical-laboratory algorithm incorporating optical density value to predict heparin-induced thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.131

Biology of recombinant hirudin (CGP 39393): a new prospect in the treatment of thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.131

Pharmacology of recombinant hirudin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.131

Hirudins: antithrombin anticoagulants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.131

Hirudin as alternative anticoagulant--a historical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.131

Desirudin dosing and monitoring in moderate renal impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.131

Prevention of deep-vein thrombosis after total hip replacement: direct thrombin inhibition with recombinant hirudin, CGP 39393.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.131

A comparison of recombinant hirudin with a low-molecular-weight heparin to prevent thromboembolic complications after total hip replacement

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.131

Generation of anti-hirudin antibodies in heparin-induced thrombocytopenic patients treated with r-hirudin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.131

Immunologic response to recombinant hirudin in HIT type II patients during long-term treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.131

Antihirudin antibodies following low-dose subcutaneous treatment with desirudin for thrombosis prophylaxis after hip-replacement surgery: incidence and clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.131

Parenteral anticoagulants: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERC.11.131

21 January 2018

Identifiers

DOI

10.1586/ERC.11.131

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21932952%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

1 reference